GlassScriptPhysician profile
Mohammad S Chaudhry
NPI 1598978850
$29,338.92
in general payments reported to CMS, 2019-2025
32 companies · $2,166 in 2025
The $2,166 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,841 · 2020: $1,979 · 2021: $745 · 2022: $836 · 2023: $1,166 · 2024: $20K · 2025: $2,166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $11K · Travel and Lodging: $8,845 · Food and Beverage: $3,176.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $10,916.67 |
| Travel and Lodging | $8,845.00 |
| Food and Beverage | $3,176.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $10,969.74 | 2023-2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac, Alphavac |
| Medtronic, INC. | $10,117.60 | 2021-2025 | Abre, Symplicity G3, Cobalt Dr Mri Surescan |
| Abbott Laboratories | $3,290.79 | 2019-2025 | Mitraclip, Triclip, Thoratec Heartmate 3 Lvas Implant Kit |
| Corindus INC. | $2,093.33 | 2019 | |
| Edwards Lifesciences Corporation | $659.68 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Boston Scientific Corporation | $311.43 | 2022-2024 | Watchman, Watchman Access System, Watchman Flx |
| Novartis Pharmaceuticals Corporation | $268.59 | 2021-2025 | |
| Bard Peripheral Vascular, INC. | $181.68 | 2024 | Venclose Maven Catheter, Lutonix Drug Coated Balloon |
| Boehringer Ingelheim Pharmaceuticals, INC. | $145.12 | 2019-2023 | Jardiance |
| Atricure, INC. | $131.32 | 2022-2024 | |
| Janssen Pharmaceuticals, INC | $103.32 | 2019-2021 | |
| Amgen INC. | $102.89 | 2019-2023 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $95.48 | 2021-2025 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $92.75 | 2019-2023 | Lifevest |
| Pfizer INC. | $92.58 | 2019-2025 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiva Medical, INC. | $81.59 | 2019-2021 | |
| W. L. Gore & Associates, INC. | $71.24 | 2023 | Gore Cardioform Septal Occluder |
| Impulse Dynamics (USA) INC. | $67.74 | 2022 | |
| Abiomed | $67.37 | 2022 | |
| Medtronic Vascular, INC. | $51.84 | 2020 | |
| Kiniksa Pharmaceuticals, LTD. | $43.58 | 2023 | Arcalyst |
| Lexicon Pharmaceuticals, INC. | $40.75 | 2024 | |
| Novo Nordisk INC | $40.18 | 2023 | Rybelsus, Ozempic |
| Scpharmaceuticals INC. | $36.67 | 2024 | |
| Penumbra, INC. | $33.18 | 2019-2020 | |
| Philips North America LLC | $33.15 | 2021-2024 | (Br5) Peripheral Ivus |
| Siemens Medical Solutions USA, INC. | $27.11 | 2024 | Syngo Dynamics |
| Heartflow, INC. | $25.06 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $17.35 | 2019 | |
| Cook Medical LLC | $16.91 | 2019 | |
| Alnylam Pharmaceuticals INC. | $15.28 | 2024 | Onpattro |
| Gilead Sciences, INC. | $13.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Chaudhry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.